Continental Investors Services Inc. Acquires Shares of 32,000 Genetic Technologies Limited (NASDAQ:GENE)

Continental Investors Services Inc. acquired a new stake in shares of Genetic Technologies Limited (NASDAQ:GENE – Get Rating) in the 3rd quarter, HoldingsChannel reports. The firm acquired 32,000 shares of the biotechnology company’s stock, valued at approximately $47,000.

Separately, OLD Mission Capital LLC purchased a new position in shares of Genetic Technologies during the 3rd quarter worth approximately $39,000. Institutional investors own 1.22% of the company’s stock.

Genetic Technologies Stock Performance

Shares of NASDAQ:GENE opened at $1.09 on Friday. Genetic Technologies Limited has a one year low of $0.83 and a one year high of $2.40. The business’s fifty day moving average price is $1.19 and its two-hundred day moving average price is $1.19. The company has a current ratio of 2.08, a quick ratio of 1.98 and a debt-to-equity ratio of 0.03.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on Genetic Technologies in a report on Wednesday. They issued a “sell” rating on the stock.

Genetic Technologies Company Profile

(Get Rating)

Genetic Technologies Ltd. is a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. It operates through EasyDNA and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The GeneType/Corporate segment includes tha GeneType branded test sales and expenses, including corporate charges.